Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas
Open Access
- 1 February 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (4) , 566-571
- https://doi.org/10.1038/bjc.1997.99
Abstract
In order to investigate the relationship between intratumoral vasculature and progression of gastric carcinomas and between vessel counts and survival of patients with non-early gastric carcinoma, we counted the intratumoral microvessels and compared their numbers with clinicopathological parameters, as well as with the patients' survival. Microvessels were stained with anti-CD34 monoclonal antibody before counting by microscopy (x200). In a group of 181 patients who had undergone tumour resection and were followed for more than 24 months the vessel counts for 83 patients with stage IV disease were significantly higher than those for patients with any other stage of disease. Among various clinicopathological variables, haematogenous metastasis, lymph node metastasis, peritoneal metastasis, stage IV disease and non-curative resection were more frequent in the patients with highly vascularized tumours (intratumoral vessel count > 155) than in those with less vascularized tumours. As a classification of stage IV disease such as haematogenous or peritoneal metastasis generally indicates non-curative resection, it can be considered that the development of stage IV disease is associated with the increase in tumour angiogenesis. Both univariate and multivariate analyses showed that the intratumoral vessel count was significantly predictive of overall survival, when tested as either a continuous or dichotomous variable. Cox hazards model analysis showed that the vessel count was one of the significant and independent prognostic variables. Patients with highly vascularized tumours were significantly more likely to die than those with less vascularized tumours. Assessment of tumour vasculature may therefore be important, not only for its prognostic value, but also as it may help to predict responses to angiogenesis-inhibiting agents.Keywords
This publication has 24 references indexed in Scilit:
- Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells?European Journal Of Cancer, 1994
- Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agentsInternational Journal of Cancer, 1994
- Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancerEuropean Journal Of Cancer, 1993
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric studyThe Journal of Pathology, 1992
- Is the relationship between angiogenesis and metastasis in breast cancer real?Surgical Oncology, 1992
- Incidence and prognostic significance of vascular invasion in 529 gastric‐cancer patientsInternational Journal of Cancer, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Neovascularization in human cutaneous melanoma: A quantitative morphological and Doppler ultrasound studyEuropean Journal of Cancer and Clinical Oncology, 1986